Best Life Sciences Platforms and Tools Companies in British Columbia, Canada
The 52 best Life Sciences Platforms and Tools companies in British Columbia, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Precision Nanosystems.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in British Columbia
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Abmgood Provider of research reagents and custom services for the life science research industry | — | — | 73 | 2014 | — | Top 1M | — | 1 launch · 1 partnership |
| 2 | acmelabs AcmeLabs provides a full range of sample preparation, assaying and geo-analytical services. | — | — | 978 | 1971 | — | — | — | — |
| 3 | Advanced Protein Technology Recombinant proteins for research | — | — | — | 2011 | Chen Yongliang CEO | — | — | — |
| 4 | Agro Epigenetics Development of stable traits in crops by epigenetic gene silencing | — | — | — | 2015 | Michael Westhaver Chairman & CEO | — | — | — |
| 5 | Apricell Biotechnology Developer of drug discovery and precision therapy platform for oncology | — | — | 3 | 2021 | — | — | 3 patents Microfluidic 3D cell/ organoid culture platforms for disease modeling and drug screening | — |
| 6 | artron bioresearch Artron Bioresearch specializes in the development and production of antibodies and antigens manufactured… | — | — | 10 | 2002 | — | — | — | — |
| 7 | Aurora Biomed Manufacturer of automated liquid handling systems, spectroscopic platforms and ion channel assay platforms | — | — | — | 1998 | Dong Liang CEO | Top 5M | — | — |
| 8 | Axolotl Biosciences Provider of reagents and consulting services in the field of 3D bioprinting | — | — | 10 | 2020 | Laura Vega Co-Founder | — | — | — |
Top 12 Life Sciences Platforms and Tools companies in British Columbia
#1
Series A · Victoria, British Columbia · founded 2020 · 15 employees$1.3Mraised▾
Manufacturer of 3D bioprinters. It develops 3D bio-printers and bio-inks for drug development and tissue engineering. Its technology uses lasers that crosslink liquid polymers and bio-inks. It applies to the manufacturing of biomimetic tissues that reduce the time and cost of drug testing.
- Feb 2025Series A$1.7M
- Dec 2023Series A$1.5M
- Nov 2022Grant (prize money)—
- Aug 2022Seed$1.3M
#2
Public · Victoria, British Columbia · founded 1989 · 80 employees$18.4Mraised▾
CDMO focused on antibody discovery and pre-clinical services
- Jul 2024Post IPO$2M
- Jul 2020Grant (prize money)—
- Apr 2020Post IPO$1.8M
- Apr 2020Grant (prize money)$75K
#3
Funding Raised · Burnaby, British Columbia · founded 1999$625.5Kraised▾
Developer of small molecules to modulate intracellular messenger RNA using a proprietary discovery platform. The company is using its proprietary technology Quest to discover small molecules. The technology involves identification of mRNA stability regulatory elements (SCEs); cloning of the target SCE into a relevant diseased cell and then the production of stable cell line; screening of compound libraries.
- Mar 2025Grant (prize money)$625.5K
#4
Public · Kelowna, British Columbia · founded 2004 · 6 employees$8.3Mraised▾
Developer of drug delivery technology designed to improve drug absorption. The technology enhances the effectiveness of active pharmaceutical ingredients. It formulates therapeutics into oral formats like tablets and suspensions. The technology is available for licensing to improve existing or create new products.
- Oct 2023Post IPO$1.6M
- Dec 2021Post IPO$1.2M
- Jul 2020Post IPO$100K
- May 2020Post IPO$2M
#5
Acquired · Vancouver, British Columbia · founded 2010 · 150 employees$25.4Mraised▾
Manufactures instruments, kits, and reagents for nanomedicine development. NanoAssemblr is a benchtop instrument that enables molecular self-assembly of nanoparticles via a custom-engineered microfluidic mixing chip. Its sub kits include Neuro9, a lipid nanoparticle used for potent delivery of small molecules or nucleic acids (eg. siRNA, miRNA) to primary cells, and Test9, nanoparticles to mediate uptake of RNA into cells.
- Aug 2022Grant (prize money)$59.1K
- Feb 2021Grant (prize money)$19.6M
- Oct 2020Grant (prize money)$19.1M
- Nov 2019Series B$6M
#6
Acquired · Vancouver, British Columbia · founded 2013 · 34 employees$22.1Mraised▾
ARTMS is a developer of radioisotope technologies. The company offers technological services to enable the development of radioisotope technologies. The flagship product QIS enables turnkey production of purified radiometals by radioisotope material developers.
- Feb 2021Grant (prize money)$300K
- May 2020Series A$18.8M
- Aug 2019Series A$1.5M
- Dec 2017Series A$3M
#7
Series A · Vancouver, British Columbia · founded 1993 · 129 employees$11.9Mraised▾
Developer of cell culture media and ancillary reagents for life science research. The company's offerings include products for isolating, culturing, and assaying cells, as well as services and training programs aimed at supporting scientists in their research endeavors.
- Apr 2021Grant (prize money)$1.1M
- Jan 2020Grant (prize money)$625.9K
- Nov 2019Grant (prize money)$17K
- Aug 2019Conventional Debt—
#8
Series B · Burnaby, British Columbia · founded 2000$19.4Mraised▾
Provider of scientific research and publication services. The company offers a platform for researchers to publish their findings across various scientific disciplines. Content covers a wide range of topics, including immunology, virology, and veterinary science. The platform facilitates the dissemination of research through articles and publications, contributing to the advancement of scientific knowledge. The focus is on providing a readily accessible resource for scientific information.
- Aug 2013Venture Debt—
- Jul 2013Venture Debt—
- Dec 2012Post IPO$4.6M
- Aug 2012Post IPO$2.5M
#9
Deadpooled · Vancouver, British Columbia · founded 2008 · 7 employees$9.9Mraised▾
LightIntegra engages in developing, manufacturing, and marketing ThromboLUX which detects platelet microparticle content. The product is based on dynamic light scattering technology and determines the size and distribution of particles that are in a platelet sample. The instrument comes with a sample kit and comes with a proprietary algorithm to calculate and analyze the size distribution at each temperature.
- Apr 2020Series A$1.1M
- Apr 2019Series A$5.3M
- Dec 2017Series A$3.5M
#10
Series A · Victoria, British Columbia · founded 2006 · 4 employees$5Mraised▾
MedGenesis Therapeutix develops and commercializes therapeutics for neurological diseases. Offers Convection Enhanced Delivery (CED), a minimally invasive technique for targeted, local treatment of CNS conditions such as Parkinson’s disease, epilepsy, brain cancer and other severely debilitating diseases of the CNS. The company's GDNF program has been supported by a grant from the Michael J Fox Foundation for Parkinson's Research, and benefitted from a direct grant from Parkinson's UK to an investigator-sponsored clinical trial being conducted by the North Bristol Trust. Has strategic collaborations and partnerships with BrainLAB AG, Renishaw, and Northern Lipids.
- Jan 2012Series A$5M
#11
Series A · Vancouver, British Columbia · founded 1999$4Mraised▾
Interomex BioPharmaceuticals is a functional proteomics biotechnology company. The company has developed a proprietary yeast-based repressed transcription activator (RTA) platform to identify inhibitors of protein-protein interactions and interactions of gene transactivating proteins that play central roles in many diseases. The RTA system was developed in the laboratory of Dr Ivan Sadowski at the University of British Columbia.
- Oct 2001Series A$4M
#12
Seed · Vancouver, British Columbia · founded 1999$2.3Mraised▾
Kinexus Bioinformatics Corporation provides proteomics services for tracking protein kinases and other cell signaling proteins. It also provides antibodies, peptides, and other reagents for proteomics study. It offers services in the areas of cell culture, immunoblotting, substrate profiling, inhibitor profiling, microarray analysis antibody, and peptide production, custom graphic, online KiNET DataBank, protein determination/identification and production, SigNET, western blotting analysis, cell and tissue lysates scanning, mass spectrometry, quality control, maintenance, troubleshooting, technical support, and data security aspects.
- Mar 2016Grant (prize money)—
- Sep 2015Grant (prize money)—
- 2011Angel$150K
- May 2002Unattributed$500K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Canada
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,804 Canada-affiliated papers.
- Ministry of Education187
- University of Toronto155
- University of British Columbia117
- McGill University108
- Ministry of Agriculture72
- Gene8→75
- Genome16→64
- Transcriptome2→41
- Immune system1→24
- Drug discovery2→21
- Microbiome1→19
- Gut flora1→18
- Metabolomics2→17
- Genome4→18
- Drug discovery1→10
- Disease2→55
- Clinical trial1→24
- Immune system1→19
- Gene1→19
- Epigenetics1→13
Where bioinformatics is researched across Canada
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.